• Technology and Data
  • Front End Sales and Marketing
  • Allergy
  • HIV
  • Women's Health
  • Migraine
  • Compounding
  • Continuous Glucose Monitoring
  • Mental Health Awareness
  • Veterinary Pharmacy
  • CBD
  • Infectious Disease
  • Eye Health
  • Digestive Health
  • Biosimilars
  • Influenza
  • Shingles
  • COPD Management
  • Pediatrics
  • Generics
  • Pain Management
  • COVID-19
  • Immunization
  • Oncology
  • Anticoagulants
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Respiratory
  • Heart Health
  • Cardiovascular Clinical Consult

New Rx, OTC, and generics (August 2010)


A survey of new Rx, new generic, and new OTC products

Key Points


New drugs

Takeda's ACTOplus met XR is an extended-release version of the combination medication ACTOplus met (pioglitazone HCl and metformin HCl), for the treatment of type 2 diabetes as an adjunct to diet and exercise. ACTOplus met XR is available in pioglitazone/metformin XR 15 mg/1000 mg and 30 mg/1000 mg dosage strengths. ( http://www.tpna.com/877-825-3327)

Merck announced FDA approval of Dulera Inhalation Aerosol, a new fixed-dose combination asthma treatment for patients 12 years of age and older. Dulera combines an inhaled corticosteroid (mometasone furoate) with a long-acting beta2-agonist (formoterol fumarate dihydrate). ( http://www.merck.com/)

FDA has approved Abbott's redesigned FreeStyle blood glucose test strips. The new test strips use a GDH-FAD enzyme unaffected by common nonglucose sugars, minimizing the potential for interference. The test strips are compatible with all FreeStyle blood-glucose monitoring systems. ( http://www.myfreestyle.com/888-522-5226)

FDA has approved Tasigna (nilotinib) 150-mg capsules from Novartis for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna is the first new therapeutic option for newly diagnosed patients since the introduction of Gleevec (imatinib mesylate) tablets, providing a major advance for patients with this blood cancer. ( http://www.us.novartis.com/)

Related Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
Dr. Charles Lee
© 2023 MJH Life Sciences

All rights reserved.